A new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann ...
Bluejay Therapeutics, Inc., a clinical-stage biopharmaceutical company rapidly progressing transformative therapies for viral ...
News Medical on MSN12h
Understanding the mechanisms behind alcohol-associated liver diseaseA newly published review in eGastroenterology compiles recent research on alcohol-associated liver disease (ALD), offering an overview of its pathogenesis and efforts to better understand this ...
RedePHine phase 1/2 clinical trial initiation expected in first half of 2025CAMBRIDGE, Mass., Dec. 19, 2024 (GLOBE NEWSWIRE) ...
GlobalData on MSN14h
Karmanos Cancer Institute commences prescription of liver cancer deviceThe Barbara Ann Karmanos Cancer Institute, a part of McLaren Health Care, has commenced the prescription of a new ...
Deubiquitinases (DUBs) are enzymes used by cells to trim protein modifications made from the protein ubiquitin, and thereby ...
2024 marked a big year for the field of xenotransplantation, with surgical teams at several health systems completing historic procedures that could pave the way for broader adoption of ...
New DESTINY-Breast06 analysis showed trastuzumab deruxtecan doubled PFS versus chemotherapy in patients with rapid ...
Histotripsy is a new, FDA-approved, minimally invasive technique that destroys liver tumors using high-frequency ultrasound ...
Chronic liver damage can lead to hepatitis, which causes fibrosis of the liver. This buildup of collagen and other fibrous ...
News Medical on MSN16h
AHCC supplement shows potential in protecting the liver from fibrosisChronic liver damage can lead to hepatitis, which causes fibrosis of the liver. This buildup of collagen and other fibrous ...
What’s more, Alecensa in April jumped into early-stage disease with a first-in-class FDA nod to treat ALK-positive NSCLC as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback